Skip to content
Search

Latest Stories

MPs report slams failure of Covid tracing

The government largely wasted a mammoth £37 billion on a test and trace programme that failed to control the spread of Covid-19 last year, a report by lawmakers said on Wednesday (October 27).

The government and its inexperienced head for the programme, Dido Harding, displayed "gung-ho confidence", the chair of the House of Commons public accounts committee said.


"But in the end it massively over-promised for what it delivered and it was eye-watering sums of money," Meg Hillier, of the opposition Labour party, told BBC radio.

"That is one of the biggest concerns -- it is almost as if the taxpayer was an ATM machine. That lack of regard for taxpayer funding is a real concern for us as a committee," she said.

When the pandemic erupted early last year, Britain tried to build from scratch a mass programme to test for new cases and trace infected people.

But its caseload soon exploded and the country now has the second-highest death toll in Europe, behind Russia.

The MPs' report said Harding and the government had relied too much on expensive outside contractors instead of existing networks in the NHS.

Uptake of services offered by the programme was "variable" and "only a minority of people experiencing Covid-19 symptoms get a test", the report said.

Overall, it concluded, the scheme "has not achieved its main objective to help break chains of Covid-19 transmission and enable people to return towards a more normal way of life".

The government defended the testing programme, insisting that more people now receive tests than in any other European country.

Jenny Harries, head of the UK Health Security Agency, said it was "saving lives every single day and helping us fight Covid-19 by breaking chains of transmission and spotting outbreaks wherever they exist".

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less